XC001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for XC001, covering 2024-01-30 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG [Phase 2]